Factors Affecting Genomic Testing in Prostate Cancer: Results From the Decision-Making, Experience, and Confidence In Determining Genomic Evaluation (DECIDE) Survey
Bitting R, McNair C, Wyatt A, Vandekerkhove G, Choi T, Leader A, Blanding-Godbolt J, Gross L, Hamade K, Halabi S, Giri V. Factors Affecting Genomic Testing in Prostate Cancer: Results From the Decision-Making, Experience, and Confidence In Determining Genomic Evaluation (DECIDE) Survey. JCO Precision Oncology 2025, 9: e2400821. PMID: 40373262, DOI: 10.1200/po-24-00821.Peer-Reviewed Original ResearchConceptsGenomic testingTraining of health care professionalsHereditary cancer assessmentSomatic genomic testingHealth care providersHealth care professionalsAcademic medical centerLack of educationSelf-confidenceProvider confidenceCare providersCare professionalsCommon barriersSurvey domainsProstate cancerPractical barriersMultiple-response questionsTest utilizationMedical oncologistsMedical CenterEnhanced implementationDecision-making factorsProvidersDecision-makingPercentage of responsesGermline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline Clinical Insights.
Giri V, Rumble R, Yu E, Lu K. Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline Clinical Insights. JCO Oncology Practice 2025, op2500186. PMID: 40239123, DOI: 10.1200/op-25-00186.Peer-Reviewed Original ResearchGermline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline
Yu E, Rumble R, Agarwal N, Cheng H, Eggener S, Bitting R, Beltran H, Giri V, Spratt D, Mahal B, Lu K, Crispino T, Trabulsi E. Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline. Journal Of Clinical Oncology 2025, 43: 748-758. PMID: 39787437, DOI: 10.1200/jco-24-02608.Peer-Reviewed Original ResearchConceptsMetastatic prostate cancerSomatic genomic testingProstate cancerMetastatic castration-resistant prostate cancerClinical trialsCastration-resistant prostate cancerGenomic testingPoly(ADP-ribose) polymerase inhibitorsSystematic reviewMetastatic biopsiesSurvival benefitASCO guidelinesPrognostic informationClinical statusGermline testingPolymerase inhibitorsPatientsScreening implicationsPubMed databaseCancerMultidisciplinary panelEligibility criteriaGermlineLiterature searchSequencing findings
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply